/Investor DB

Merida Capital Holdings — 2019 Investments

1 investments dated 2019 · listed companies and verified rows first · show all

Rev Genomicsrevgenomics.cominApr 2019

Rev Genomics is a plant biotechnology company that develops novel plant cultivars.

AgTechBiotechDeep TechHealthtechMedical DevicesSan Francisco, US

Bertrand Vick(Founder/CEO)inRobert John Markelz(Executive Officer, Director, Promoter)Gloria E Webster(Director, Promoter)Robert Markelz(Vice President of Genomics)

Co-investorsY CombinatorAdditionAgrolimen VenturesFloret VenturesGron Ventures, LlcL4 Inc.+3 more

Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.